September 30, 2016 2:02 PM ET

Biotechnology

Company Overview of Xsira Pharmaceuticals, Inc.

Executive Profile

Roger D. Blevins Pharm. D.

Chief Executive Officer, President and Director, Xsira Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 3 different industries.

See Board Relationships
60--

Background

Dr. Roger D. Blevins, Pharm. D., has been the President and Chief Executive officer of Xsira Pharmaceuticals, Inc., since June 28, 2000. Previously, he served as the President and Chief Executive Officer of King Pharmaceuticals Research & Development Inc., (formerly, Medco Research, Inc.) since February 1998. He is a pharmacologist with over 18 years of experience in academia and industry. He served as the President of Medco Research, Inc., from 1995 to 1999. Previously, ...

Corporate Headquarters

7030 Kit Creek Road
Morrisville, North Carolina 27560

United States

Phone: 919-248-8000
Fax: 919-248-8033

Board Members Memberships

Chief Executive Officer, President and Director
Chief Executive Officer, President and Director

Education

Doctorate
Wayne State University
Bachelor's Degree
Wayne State University
BS 1980
Wayne State University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Xsira Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.